1. Home
  2. Author
  3. Subbanna S

Subbanna S

References (2)

Title : Preclinical and randomized clinical evaluation of the p38alpha kinase inhibitor neflamapimod for basal forebrain cholinergic degeneration - Jiang_2022_Nat.Commun_13_5308
Author(s) : Jiang Y , Alam JJ , Gomperts SN , Maruff P , Lemstra AW , Germann UA , Stavrides PH , Darji S , Malampati S , Peddy J , Bleiwas C , Pawlik M , Pensalfini A , Yang DS , Subbanna S , Basavarajappa BS , Smiley JF , Gardner A , Blackburn K , Chu HM , Prins ND , Teunissen CE , Harrison JE , Scheltens P , Nixon RA
Ref : Nat Commun , 13 :5308 , 2022
Abstract : Jiang_2022_Nat.Commun_13_5308
ESTHER : Jiang_2022_Nat.Commun_13_5308
PubMedSearch : Jiang_2022_Nat.Commun_13_5308
PubMedID: 36130946

Title : Postnatal ethanol exposure alters levels of 2-arachidonylglycerol-metabolizing enzymes and pharmacological inhibition of monoacylglycerol lipase does not cause neurodegeneration in neonatal mice - Subbanna_2015_J.Neurochem_134_276
Author(s) : Subbanna S , Psychoyos D , Xie S , Basavarajappa BS
Ref : Journal of Neurochemistry , 134 :276 , 2015
Abstract : Subbanna_2015_J.Neurochem_134_276
ESTHER : Subbanna_2015_J.Neurochem_134_276
PubMedSearch : Subbanna_2015_J.Neurochem_134_276
PubMedID: 25857698